Cited by 66

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

The emerging role of retromer in neuroprotection

McMillan, Kirsty J, Korswagen, Hendrick C, Cullen, Peter J·2017·Current Opinion in Cell Biology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ceb.2017.02.004

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Perturbed endosomal transport is a contributing factor and, in some cases, a causative factor in human diseases, including neurodegenerative and neurological, and metabolic syndromes and cardiovascular disease.

    “An increasing body of evidence points to perturbed endosomal transport being a contributing factor and, in some cases, a causative factor in human diseases, including neurodegenerative and neurological2–4, and metabolic syndromes and cardiovascular disease5.”
  • Sub-domain dysfunction is associated with human disease.

    “Sub-domain dysfunction is associated with human disease, but our mechanistic understanding of its function remains poorly described.”
  • Functional retrieval sub-domains are essential for development and homeostasis, and disease-associated sub-domain dysregulation is associated with human disease.

    “Analysis in cells and organisms have established the essential importance of functional retrieval sub-domains for development and homeostasis, and disease-associated sub-domain dysregulation is associated with human disease2–5.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 82

  1. Huotari, 2011, Endosome maturation, EMBO J., 30, 3481, 10.1038/emboj.2011.286 · DOI
  2. Wang, 2015, The retromer complex in development and disease, Development, 142, 2392, 10.1242/dev.123737 · DOI
  3. Henne, 2013, Molecular mechanisms of the membrane sculpting ESCRT pathway, Cold Spring Harb. Perspect. Biol., 5, 10.1101/cshperspect.a016766 · DOI
  4. Hsu, 2012, Getting active: protein sorting in endocytic recycling, Nat. Rev. Mol. Cell Biol., 13, 323, 10.1038/nrm3332 · DOI
  5. Seaman, 2012, The retromer complex—endosomal protein recycling and beyond, J. Cell Sci., 125, 4693
  6. Small, 2015, Retromer in Alzheimer disease, Parkinson disease and other neurological disorders, Nat. Rev. Neurosci., 16, 126, 10.1038/nrn3896 · DOI · Paper page
  7. Cullen, 2011, Sorting nexins provide diversity for retromer-dependent trafficking events, Nat. Cell Biol., 14, 29, 10.1038/ncb2374 · DOI · Paper page
  8. Ehringer, 1960, Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system, Klin. Wochenschr., 38, 1236, 10.1007/BF01485901 · DOI
  9. Bernheimer, 1973, Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations, J. Neurol. Sci., 20, 415, 10.1016/0022-510X(73)90175-5 · DOI
  10. Ferrer, 2011, Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease, J. Neural Transm. (Vienna), 118, 821, 10.1007/s00702-010-0482-8 · DOI
  11. Vilarino-Guell, 2011, VPS35 mutations in Parkinson disease, Am. J. Hum. Genet., 89, 162, 10.1016/j.ajhg.2011.06.001 · DOI · Paper page
  12. Zimprich, 2011, A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease, Am. J. Hum. Genet., 89, 168, 10.1016/j.ajhg.2011.06.008 · DOI · Paper page
  13. Shannon, 2014, Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson’s disease, Neurobiol. Aging, 35, 1958, 10.1016/j.neurobiolaging.2014.03.004 · DOI · Paper page
  14. Gustavsson, 2015, Genetic variability of the retromer cargo recognition complex in parkinsonism, Mov. Disord., 30, 580, 10.1002/mds.26104 · DOI · Paper page
  15. Deng, 2013, The VPS35 gene and Parkinson’s disease, Mov. Disord., 28, 569, 10.1002/mds.25430 · DOI
  16. Bandres-Ciga, 2016, Analysis of the genetic variability in Parkinson’s disease from Southern Spain, Neurobiol. Aging, 37, 210, 10.1016/j.neurobiolaging.2015.09.020 · DOI
  17. Nuytemans, 2013, Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease, Neurology, 80, 982, 10.1212/WNL.0b013e31828727d4 · DOI
  18. Trinh, 2014, Disease penetrance of late-onset parkinsonism: a meta-analysis, JAMA Neurol., 71, 1535, 10.1001/jamaneurol.2014.1909 · DOI
  19. McMillan, 2016, Atypical parkinsonism-associated retromer mutant alters endosomal sorting of specific cargo proteins, J. Cell Biol., 214, 389, 10.1083/jcb.201604057 · DOI
  20. Follett, 2016, Parkinson disease-linked Vps35 R524W mutation impairs the endosomal association of retromer and induces alpha-synuclein aggregation, J. Biol. Chem., 291, 18283, 10.1074/jbc.M115.703157 · DOI · Paper page
  21. MacLeod, 2013, RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson’s disease risk, Neuron, 77, 425, 10.1016/j.neuron.2012.11.033 · DOI · Paper page
  22. Linhart, 2014, Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson’s disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2), Mol. Neurodegener., 9, 23, 10.1186/1750-1326-9-23 · DOI
  23. Bi, 2013, Pathogenic mutation in VPS35 impairs its protection against MPP(+) cytotoxicity, Int. J. Biol. Sci., 9, 149, 10.7150/ijbs.5617 · DOI
  24. Tsika, 2014, Parkinson’s disease-linked mutations in VPS35 induce dopaminergic neurodegeneration, Hum. Mol. Genet., 23, 4621, 10.1093/hmg/ddu178 · DOI · Paper page
  25. Trinh, 2013, Advances in the genetics of Parkinson disease, Nat. Rev. Neurol., 9, 445, 10.1038/nrneurol.2013.132 · DOI
  26. Seaman, 1998, A membrane coat complex essential for endosome-to-Golgi retrograde transport in yeast, J. Cell Biol., 142, 665, 10.1083/jcb.142.3.665 · DOI · Paper page
  27. Seaman, 2004, Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer, J. Cell Biol., 165, 111, 10.1083/jcb.200312034 · DOI · Paper page
  28. Arighi, 2004, Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor, J. Cell Biol., 165, 123, 10.1083/jcb.200312055 · DOI · Paper page
  29. Cullen, 2009, Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo, Mol. Brain, 2, 5, 10.1186/1756-6606-2-5 · DOI
  30. Sevlever, 2008, Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species, Biochemistry, 47, 9678, 10.1021/bi800699v · DOI · Paper page
  31. Spillantini, 1997, Alpha-synuclein in Lewy bodies, Nature, 388, 839, 10.1038/42166 · DOI · Paper page
  32. Dehay, 2013, Lysosomal impairment in Parkinson’s disease, Mov. Disord., 28, 725, 10.1002/mds.25462 · DOI · Paper page
  33. Zavodszky, 2014, Mutation in VPS35 associated with Parkinson’s disease impairs WASH complex association and inhibits autophagy, Nat. Commun., 5, 3828, 10.1038/ncomms4828 · DOI · Paper page
  34. Miura, 2014, VPS35 dysfunction impairs lysosomal degradation of alpha-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson’s disease, Neurobiol. Dis., 71, 1, 10.1016/j.nbd.2014.07.014 · DOI
  35. Dhungel, 2015, Parkinson’s disease genes VPS35 and EIF4G1 interact genetically and converge on alpha-synuclein, Neuron, 85, 76, 10.1016/j.neuron.2014.11.027 · DOI
  36. McGough, 2014, Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation, Curr. Biol., 24, 1670, 10.1016/j.cub.2014.06.024 · DOI · Paper page
  37. Follett, 2014, The Vps35 D620N mutation linked to Parkinson’s disease disrupts the cargo sorting function of retromer, Traffic, 15, 230, 10.1111/tra.12136 · DOI
  38. Dahms, 2008, Strategies for carbohydrate recognition by the mannose 6-phosphate receptors, Glycobiology, 18, 664, 10.1093/glycob/cwn061 · DOI
  39. Zhao, 2014, Lysosome sorting of beta-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor, Nat. Commun., 5, 4321, 10.1038/ncomms5321 · DOI
  40. Coutinho, 2012, A shortcut to the lysosome: the mannose-6-phosphate-independent pathway, Mol. Genet. Metab., 107, 257, 10.1016/j.ymgme.2012.07.012 · DOI
  41. Manzoni, 2013, Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies, FASEB J., 27, 3424, 10.1096/fj.12-223842 · DOI
  42. Sidransky, 2012, The link between the GBA gene and parkinsonism, Lancet Neurol., 11, 986, 10.1016/S1474-4422(12)70190-4 · DOI
  43. Reitz, 2015, The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review, Mol. Genet. Genom., 290, 413, 10.1007/s00438-014-0939-9 · DOI
  44. Cuervo, 1996, A receptor for the selective uptake and degradation of proteins by lysosomes, Science, 273, 501, 10.1126/science.273.5274.501 · DOI · Paper page
  45. Gomez, 2009, A FAM21-containing WASH complex regulates retromer-dependent sorting, Dev. Cell, 17, 699, 10.1016/j.devcel.2009.09.009 · DOI · Paper page
  46. Derivery, 2009, The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex, Dev. Cell, 17, 712, 10.1016/j.devcel.2009.09.010 · DOI · Paper page
  47. Seaman, 2013, Retromer-mediated endosomal protein sorting: all WASHed up!, Trends Cell Biol., 23, 522, 10.1016/j.tcb.2013.04.010 · DOI
  48. Vilarino-Guell, 2014, DNAJC13 mutations in Parkinson disease, Hum. Mol. Genet., 23, 1794, 10.1093/hmg/ddt570 · DOI
  49. Freeman, 2014, RME-8 coordinates the activity of the WASH complex with the function of the retromer SNX dimer to control endosomal tubulation, J. Cell Sci., 127, 2053
  50. King, 2013, WASH is required for lysosomal recycling and efficient autophagic and phagocytic digestion, Mol. Biol. Cell, 24, 2714, 10.1091/mbc.e13-02-0092 · DOI
  51. Xia, 2013, WASH inhibits autophagy through suppression of Beclin 1 ubiquitination, EMBO J., 32, 2685, 10.1038/emboj.2013.189 · DOI
  52. Temkin, 2011, SNX27 mediates retromer tubule entry and endosome-to-plasma membrane trafficking of signalling receptors, Nat. Cell Biol., 13, 715, 10.1038/ncb2252 · DOI · Paper page
  53. Zech, 2011, The Arp2/3 activator WASH regulates alpha5beta1-integrin-mediated invasive migration, J. Cell Sci., 124, 3753, 10.1242/jcs.080986 · DOI · Paper page
  54. Wang, 2016, VPS35 regulates cell surface recycling and signaling of dopamine receptor D1, Neurobiol. Aging, 46, 22, 10.1016/j.neurobiolaging.2016.05.016 · DOI
  55. Ishizu, 2016, Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice, Hum. Mol. Genet., 25, 4507
  56. Berwick, 2014, The regulation and deregulation of Wnt signaling by PARK genes in health and disease, J. Mol. Cell Biol., 6, 3, 10.1093/jmcb/mjt037 · DOI
  57. Munsie, 2015, Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson’s disease VPS35 mutation p. D620N, Hum. Mol. Genet., 24, 1691, 10.1093/hmg/ddu582 · DOI · Paper page
  58. Sowada, 2016, Increased copper toxicity in Saccharomyces cerevisiae lacking VPS35, a component of the retromer and monogenic Parkinson disease gene in humans, Biochem. Biophys. Res. Commun., 476, 528, 10.1016/j.bbrc.2016.05.157 · DOI
  59. Steinberg, 2013, A global analysis of SNX27-retromer assembly and cargo specificity reveals a function in glucose and metal ion transport, Nat. Cell Biol., 15, 461, 10.1038/ncb2721 · DOI · Paper page
  60. Davies, 2016, Copper dyshomoeostasis in Parkinson’s disease: implications for pathogenesis and indications for novel therapeutics, Clin. Sci. (Lond.), 130, 565, 10.1042/CS20150153 · DOI
  61. Piotrowski, 2013, WASH knockout T cells demonstrate defective receptor trafficking, proliferation, and effector function, Mol. Cell. Biol., 33, 958, 10.1128/MCB.01288-12 · DOI · Paper page
  62. Clairfeuille, 2016, A molecular code for endosomal recycling of phosphorylated cargos by the SNX27-retromer complex, Nat. Struct. Mol. Biol., 23, 921, 10.1038/nsmb.3290 · DOI · Paper page
  63. Joubert, 2004, New sorting nexin (SNX27) and NHERF specifically interact with the 5-HT4a receptor splice variant: roles in receptor targeting, J. Cell Sci., 117, 5367, 10.1242/jcs.01379 · DOI
  64. Gallon, 2014, A unique PDZ domain and arrestin-like fold interaction reveals mechanistic details of endocytic recycling by SNX27-retromer, Proc. Natl. Acad. Sci. U. S. A., 111, E3604, 10.1073/pnas.1410552111 · DOI · Paper page
  65. Lee, 2016, FAM21 directs SNX27-retromer cargoes to the plasma membrane by preventing transport to the Golgi apparatus, Nat. Commun., 7, 10939, 10.1038/ncomms10939 · DOI · Paper page
  66. Cai, 2011, Deficiency of sorting nexin 27 (SNX27) leads to growth retardation and elevated levels of N-methyl-d-aspartate receptor 2C (NR2C), Mol. Cell. Biol., 31, 1734, 10.1128/MCB.01044-10 · DOI
  67. Wang, 2013, Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down’s syndrome, Nat. Med., 19, 473, 10.1038/nm.3117 · DOI · Paper page
  68. Damseh, 2015, A defect in the retromer accessory protein, SNX27, manifests by infantile myoclonic epilepsy and neurodegeneration, Neurogenetics, 16, 215, 10.1007/s10048-015-0446-0 · DOI · Paper page
  69. Hussain, 2014, Sorting Nexin 27 regulates basal and activity-dependent trafficking of AMPARs, Proc. Natl. Acad. Sci. U. S. A., 111, 11840, 10.1073/pnas.1412415111 · DOI · Paper page
  70. Loo, 2014, A role for sorting nexin 27 in AMPA receptor trafficking, Nat. Commun., 5, 3176, 10.1038/ncomms4176 · DOI · Paper page
  71. Davis, 1979, Chronic Parkinsonism secondary to intravenous injection of meperidine analogues, Psychiatry Res., 1, 249, 10.1016/0165-1781(79)90006-4 · DOI
  72. Langston, 1983, Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis, Science, 219, 979, 10.1126/science.6823561 · DOI · Paper page
  73. Braschi, 2010, Vps35 mediates vesicle transport between the mitochondria and peroxisomes, Curr. Biol., 20, 1310, 10.1016/j.cub.2010.05.066 · DOI
  74. Tang, 2015, VPS35 deficiency or mutation causes dopaminergic neuronal loss by impairing mitochondrial fusion and function, Cell Rep., 12, 1631, 10.1016/j.celrep.2015.08.001 · DOI
  75. Wang, 2016, Parkinson’s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes, Nat. Med., 22, 54, 10.1038/nm.3983 · DOI
  76. Wang, 2016, A conserved retromer sorting motif is essential for mitochondrial DLP1 recycling by VPS35 in Parkinson’s disease model, Hum. Mol. Genet., 10.1093/hmg/ddw430 · DOI
  77. Prudent, 2015, MAPL SUMOylation of Drp1 stabilizes an ER/mitochondrial platform required for cell death, Mol. Cell, 59, 941, 10.1016/j.molcel.2015.08.001 · DOI
  78. McLelland, 2014, Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control, EMBO J., 33, 282
  79. Chen, 2013, PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria, Science, 340, 471, 10.1126/science.1231031 · DOI · Paper page
  80. Malik, 2015, VPS35 pathogenic mutations confer no dominant toxicity but partial loss of function in Drosophila and genetically interact with parkin, Hum. Mol. Genet., 24, 6106, 10.1093/hmg/ddv322 · DOI
  81. Mecozzi, 2014, Pharmacological chaperones stabilize retromer to limit APP processing, Nat. Chem. Biol., 10, 443, 10.1038/nchembio.1508 · DOI · Paper page
  82. Lucas, 2016, Structural mechanism for cargo recognition by the retromer complex, Cell, 1623, 10.1016/j.cell.2016.10.056 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
McMillan, K. J., Korswagen, H. C., & Cullen, P. J.
Venue
Current Opinion in Cell Biology
Publisher
Elsevier BV
Published
2017-08
Volume
47
Pages
72-82
ISSN
0955-0674
Cited by
66
References
5
Language
en
Funders
  • Medical Research Council (MR/K018299/1)
  • Wellcome Trust (104568, 089928)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review